Purity is published only against a lot-matched COA.
£34.99
Qty
1
Total
£34.99
In stock · ships today
Research use only · Not for human or veterinary use
Guaranteed safe checkoutVISAMASTERCARDAMEX
Third-party HPLC tested
Certificate for every lot
Tracked, discreet shipping
Secure checkout
Research use only • Not for human or veterinary use
Peptide research material · Capsule format
Grindlab Ipamorelin
Supplied as a single-compound peptide in a clearly labelled capsule format, at 5 mg per capsule and 30 capsules per bottle. The submitted sample carries an independent Janoshik laboratory report, shown in full below with the reported amount per tested capsule.
The supplied laboratory information covers a single Ipamorelin capsule sample, labelled at 5 mg per capsule and supplied as 30 capsules in one Grindlab bottle. The label value and the laboratory-reported amount are kept distinct throughout.
Labelled strength5 mg
Labelled amount per capsule. The Janoshik record states a reported amount of 5.03 mg per tested capsule under task #65264.
Quantity30 capsules
Supplied in one Grindlab bottle. The capsule count listed on the product page matches the count recorded in the supplied documentation.
Material formatCapsules
Clearly labelled single-compound format. The submitted sample is identified in the laboratory record as Ipamorelin.
Product documentation
Label value and reported result kept separate
The product label, laboratory task number, identified material and reported capsule amount are displayed as recorded — without adding purity, batch-wide consistency or quality-control claims.
01
Clear specifications
Strength, capsule count and product format are stated directly, without hiding key details inside long descriptions.
02
Reported identity
The supplied laboratory record identifies its submitted sample as Ipamorelin, client Grindlab.
03
Quantitative result
The record states a reported amount of 5.03 mg per tested capsule against the labelled 5 mg value.
Documentation overview
How the result maps to the sample
The supplied laboratory result is connected to its submitted sample, task number and the product shown on this page.
01
Product identified
The product name, strength, format and 30-capsule quantity are clearly shown.02
Task recorded
Task #65264 corresponds to the submitted Ipamorelin capsule sample, client Grindlab.03
Amount reported
The record includes a laboratory-reported amount of 5.03 mg for the tested capsule.04
Scope stated
The result relates to the submitted sample and does not imply testing of every capsule.
Laboratory documentation
Grindlab Ipamorelin 5 mg report
The available Janoshik laboratory report identifies the submitted sample as Ipamorelin and records the reported amount in the tested capsule.
Each bottle contains Grindlab Ipamorelin capsules labelled at 5 mg per capsule, supplied as a single-compound peptide research material.
How many capsules are included?
Each bottle contains 30 capsules. The 30-capsule count is also recorded in the supplied laboratory documentation.
Is a laboratory report available?
Yes. The independent Janoshik laboratory report, task #65264, is displayed directly on this product page for review.
Are the label value and reported amount the same thing?
No. The 5 mg figure is the supplied capsule label value. The separate laboratory-reported amount is 5.03 mg in the tested capsule sample.
Does the result apply to every capsule?
The result relates to the submitted laboratory sample. The supplied information does not establish that every capsule was individually tested.
What format is the product supplied in?
The material is supplied in a clearly labelled single-compound capsule format.
What is the intended use?
This material is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.
Research use only
Grindlab Ipamorelin is supplied solely as a laboratory research material. It is not intended for human or veterinary consumption, administration, diagnosis, treatment, or performance enhancement. No representation is made regarding purity, batch-wide consistency, safety or effectiveness in humans.
